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Abstract
Background: Extensive application of measurement of 
urinary iodine concentration (UIC) in several benign and 
malignant thyroid diseases could profit by the availabil-
ity of rapid and inexpensive measuring techniques. Aim 
of this study was to apply a simple and inexpensive com-
mercially available potentiometric method for the quanti-
fication of UIC based on iodine-specific ion-selective elec-
trodes (ISE) in patients with thyroid diseases.
Methods: This retrospective study included patients with 
differentiated thyroid cancer (n = 286) and patients with 
hyperthyroidism of different etiologies (n = 203). Within 
the whole sample (n = 489) 20 patients had previously (1 
week–6 months) been exposed to iodine overload, either 
from contrast media (n = 8) or amiodarone (n = 12).
Results: In patients not exposed to iodine, the histogram 
showed that the distribution of UIC violated normality. 
The peak of the curve occurred between 5.0 μmol/L and 
6.0 μmol/L. Variability was sizeable (percent coefficient 
of variation, %CV: 66%, 95% confidence interval: 1.48–
18.72 μmol/L). The group of exposed patients could be 
easily distinguished from not exposed patients (median 
UIC: 47.5 μmol/L vs. 5.42 μmol/L). UIC was significantly 
correlated to urinary creatinine concentration, but nor-
malization to urinary creatinine increased the inter-sub-
ject variability of UIC (%CV = 96% vs. 66%). In test-retest 
studies (n = 25) the intra-class correlation coefficient was 
0.73 for UIC, 0.82 for creatinine and 0.64 for the UIC: 
 creatinine ratio.
Conclusions: Iodine-specific ISE-based potentiometric 
methods can be successfully applied as an alternative to 
existing methods in patients with thyroid diseases. The 
promising characteristics of the method need to be con-
firmed in future larger prospective studies.
Keywords: exposure to non-radioactive iodine; hyper-
thyroidism; ion-selective potentiometry; radioiodine 
therapy; urinary iodine concentration.
Introduction
There is increasing interest in the measurement of urinary 
iodine concentration (UIC). Iodine is the major component 
of thyroid hormones and neurodevelopment of the fetus 
and breast-fed infants are crucially affected by maternal 
iodine intake [1, 2]. The key indicator of population iodine 
nutrition recommended by the World Health  Organization 
(WHO) is represented by the median concentration of UIC 
measured by a 24-h collection (gold standard) or by more 
practical single spot samples [2–5]: a median UIC of at 
least 100 μg/L represents an adequate iodine nutrition in 
a population and UIC equal to 300 μg/L was set as upper 
normal limit [3]. In population-based studies of UIC, the 
reliable and feasible collection of the 24-h urine samples 
is usually not possible. Therefore, less cumbersome spot 
urine samples are used [2–4]. There is generally good 
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correlation between the single spot sample and the 24-h 
urine sample [6–8].
Knowledge of UIC is very important also in other 
medical scenarios, e.g., when diagnostic or therapeutic 
amounts of radioactivity need to be applied to patients 
with benign or malignant thyroid disease. In these 
patients iodine contamination, through iodine contrast 
media, iodine-containing medications (i.e., amiodarone), 
or chronic exposure to dietary iodine must be excluded 
[9–11].
Various methods based on different principles have 
been proposed to determine UIC. The vast majority of 
these methods measure the concentration of molecular 
iodine (I2). Such methods include electrochemical detec-
tion, spectrophotometry, chemiluminescence, polaro-
graphy, mass chromatography, gas chromatography, 
liquid chromatography and ion chromatography [12–19]. 
All these methods have some suboptimal properties 
[15,  16]. For example, analytical methods, particularly 
inductivity coupled plasma mass spectroscopy, which is 
often considered the gold standard [14], is time consum-
ing and requires expensive and complex instrumentation 
[17]. High-performance liquid chromatography methods 
based on ion chromatography or ion-paired reversed 
phase separation and detection by amperometry are 
alternative procedures, but they need special equipment 
too [18, 19]. Photometric methods, most of which make 
use of the Sandell-Kolthoff reaction, require a pretreat-
ment of the urine sample with acid digestion to remove 
several organic substances that influence the iodine cata-
lytic effect [15, 16].
In the last years, iodide (I–)-specific ion-selective 
electrodes (ISE) based on different types of ionophores, 
have been developed that are applicable to determina-
tion of UIC with high selectivity and biocompatibility 
[20–22]. Ion potentiometric sensor techniques exhibit 
high selectivity, low detection limit, are inexpensive 
and rapid and therefore suitable for application in those 
medical clinical settings where rapid decision making is 
needed based on knowledge of UIC [16, 20–24]. Over the 
last years several potentiometric devices have been built 
and validated by different manufacturers so that ready 
for use potentiometric devices are commercially avail-
able. Moreover, the applied standard addition method 
excludes potential matrix effects introduced by urine 
components [25].
Aim of this retrospective study was to use a commer-
cially available potentiometric device based on ISE to 
compare group differences in UIC among patients with 
benign and malignant thyroid diseases with and without 
previous exposure to non-radioactive iodine.
Materials and methods
Population
All patients with available UIC referred to the thyroid outpatient 
clinic of the Institute of Radiology and Nuclear Medicine of the 
Triemli Hospital, Zurich, Switzerland, between February 2013 
and March 2014 were retrospectively included in this study. Mean 
age±standard deviation (SD) was 49±18  years without significant 
(p > 0.05) differences between patients exposed to iodine and patients 
not exposed. The ratio between females and males in the population 
was 3:1. The ultimate sample of this retrospective study included 
489 patients and included patients with the following diagnosis: 
1)   differentiated thyroid cancer, n = 286 (papillary, n = 243, follicular, 
n = 43); 2)   hyperthyroidism, n = 203 (Grave’s disease, n = 96; unifocal 
adenoma or multinodular toxic goiter, n = 61; subacute thyroiditis 
de Quervain with hyperthyroid onset, n = 26; iodine-induced hyper-
thyroidism, n = 20, including n = 8 contrast media-induced hyper-
thyroidism and n = 12 amiodarone-induced hyperthyroidism).
Several physicians working in the thyroid outpatient clinic set 
the indication for the measurement of the UIC. In both groups UIC 
was measured at the first clinical evaluation and/or before radioio-
dine ablation or radioiodine therapy. In a limited number of patients 
(n = 25) two consecutive measurements of UIC within 1 week were per-
formed to assess the reproducibility of the technique. Owing to the 
retrospective design of the study, not all variables of interest were 
available in all subjects.
This single-institution study was approved by the Cantonal 
 Ethical Committee of Zurich, Switzerland and, owing to the retro-
spective design the study was waived from an informed consent.
Potentiometric measurement of UIC
Equipment: The potentiometric analysis was carried out with an 
iodide-selective electrode of Metrohm AG, 9101 Herisau, Switzerland, 
in combination with liquid junction, Ag/AgCl reference electrode 
using a 781 pH/ion meter produced by Metrohm (www.metrohm.ch).
Method: In contrast to the direct-potentiometric method, the 
known- or standard-addition-method was performed, whereby 
standards are added directly to the sample that needs to be analyzed 
[25]. This method is used in situations where sample matrix also con-
tributes to the analytical signal (matrix effect) [25]. The volume and 
concentration of the added standards were stored as parameters in 
the ion meter.
Procedure: In total 8.0 mL of urine and 4.0 mL 5.0 M NaNO3 buffer 
are added into a vial. The procedure starts with the measurement 
of the voltage of the urine sample. Subsequently, according to the 
request on the display, 25 μL, 100 μL, 250 μL and 500 μL of the 
1.0 mmol/L sodium iodide addition solutions are sequentially added. 
For each addition of sodium iodide the corresponding voltage is 
measured by the potentiometric device. These values are plotted on a 
Cartesian coordinate system, where the X-axis represents the iodine 
concentration and the Y-axis represents the voltage. Linear regres-
sion passing through the origin is used to fit these additions. The 
voltage of the urine is horizontally extrapolated to the regression line 
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Descriptive statistics in not exposed patients and in 
exposed patients are reported in Tables 1 and 2. Figure 2 
shows values of UIC among the different clinical groups of 
patients. As expected, the difference in mean UIC between 
patients with iodine-induced hyperthyroidism and the 
remaining diagnostic categories is remarkable (p < 0.001). 
Mean±SD in patients with iodine-induced hyperthyroid-
ism was 69.3±54.5 μmol/L and median was 47.5 μmol/L. 
One patient exposed to hydrophilic contrast media 
1 month before the test had UIC in the physiological range 
(9.52 μmol/L) (see Discussion). For each group the graph 
displays outliers, defined as patients with UIC  > 75% 
percentile plus 1.15 * the interquartile range, or extreme 
cases, defined as patients with UIC  > 75% percentile plus 
3 * the interquartile range. Global effect in the one-way 
ANOVA among the remaining groups did not reach statis-
tical significance (F = 0.97, p = 0.40). Consequently, UIC was 
very similar (Graves’ disease = 6.24±4.55 μmol/L, thyroid 
cancer = 6.60±4.28 μmol/L, uninodular or multinodular 
toxic goiter = 6.02±3.70 μmol/L, subacute thyroiditis de 
Quervain with hyperthyroid onset = 6.52±4.44 μmol/L). 
Note (Table 2) in not exposed subjects the high inter-sub-
ject variability in the measurement of UIC, as expressed 
by the percent coefficient of variation (%CV, 66%) or by 
the 95% confidence interval (95% CI 1.48–18.72 μmol/L). 
There was no significant difference in urinary creatinine 
concentration between exposed and not exposed patients 
(p = 0.22).
In test-retest studies in not exposed subjects base-
line UIC was 6.33±3.34 μmol/L, while retest UIC equaled 
and the intercept is identified. The UIC is then calculated by vertical 
extrapolation of this intercept to the X-axis [25, 26]. After computa-
tion, the UIC (μmol/L) is automatically printed out by the potentio-
metric device. The whole procedure requires about 30 min, including 
quality control.
Quality control: Before every run a measurement with 8.0  mL 
5.0 μmol/L sodium iodide certified solution (www.metrohm.ch) was 
performed. Every 3 months external quality control with a commer-
cially available quality control lyophilized urine (“ClinChek Level I 
and II” from www.recipe.de) was also performed.
Performance: The limit of detection (average value plus 3 standard 
deviations of 10 zero samples) was 0.05 μmol/L. Spiking tests with 
100 μL 1.0 mmol/L sodium iodide to known urine samples showed a 
recovery of 97%–100%.
Statistical analysis
Normality of the distribution of continuous variables was assessed 
graphically through histograms and formally with the Kolmogorov-
Smirnov test. Comparisons of continuous normally distributed 
variables between two groups were performed using the t-test. Com-
parisons of not normally distributed continuous variables between 
two groups were performed using the Mann-Whitney U-test. Differ-
ences between categorical variables were assessed with the χ2 test. 
Comparison of UIC among the various clinical groups was performed 
with one-way analysis of variance (ANOVA) using Fisher’s least sig-
nificant difference as post-hoc test. Correlation between UIC and 
continuous variables of interests was performed with simple linear 
regression. A multiple linear regression model was used to assess 
gender differences in UIC after correcting for thyroid volume. Test-
retest reliability was assessed with the intra-class correlation coef-
ficient using a two-way random model. Statistical significance was 
defined as p < 0.05. Statistical analysis was performed using the SPSS 
v 18 statistical software package (SPSS Inc, Chicago, IL, USA).
Results
Figure 1 shows the distribution of UIC in the sample 
(n = 469) after exclusion of patients with anamnestic evi-
dence of iodine contamination (n = 20). The distribution 
of UIC does not present a typical bell-shaped form, owing 
to an asymmetric distribution over the selected intervals 
(skewness = 1.60, kurtosis = 3.24). The Kolmogorov-Smirnov 
test indicated that values of UIC are not normally distri-
buted (p < 0.001). The peak of the curve occurs between 
5  μmol/L and 6 μmol/L, which correspond to about 
630 μg/L and 760 μg/L, respectively. The curve appears to 
level off starting by about 20 μmol/L, even though UIC of 
few patients (7/469, 1.5%) clinically judged as not exposed 
to iodine contamination were observed above this thresh-
old (see Discussion).
70
60
50
40
30
20
10
0
0 5 10 15 20 30
UIC, µmol/L
Fr
eq
ue
nc
y
25
Figure 1: Histogram of UIC in patients with thyroid disease not 
exposed to non-radioactive iodine.
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Table 1: Descriptive statistics of the urine concentration of different biochemical variables in patients not exposed to non-radioactive 
iodine (n = 469).
  Iodide, μmol/L  Iodide, μg/L  Creatinine, g/L  Iodide: creatinine, μg/g
Median   5.42  688  0.71  97.0
Mean±SD   6.45±4.27  818±542  0.92±0.76  134.2±128.7
(min–max)   (0.72–27.55)  (91–3496)  (0.06–6.91)  (12–1398)
% CV   66%  66%  83%  96%
95% CI   1.48–18.72  189–2376  0.13–2.65  21.7–437.2
Interquartile range  4.97  650  0.94  99
Table 2: Descriptive statistics of the urine concentration of different biochemical variables in patients exposed to non-radioactive iodine 
(n = 20).
  Iodide, μmol/L  Iodide, μg/L  Creatinine, g/L  Iodide: creatinine, μg/L
Median   47.5  6034  0.94  731
Mean±SD   69.3±54.5  8793±6923  1.06±0.47  1053±1010
(min–max)   (9.52–199.2)  (1208–25278)  (0.36–2.07)  (69–3685)
% CV   79%  79%  44%  96%
95% CI   9.52–198.2  1208–25156  0.36–2.07  69–3678
Interquartile range  51.0  6478  0.63  787
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Figure 2: Box-and-whisker plot of the UIC (μmol/L) in the different 
diagnostic groups.
The ends of the whiskers represent minimum and maximum values. 
○ represents outliers, * represents extreme cases (see text fur 
further details).
Figure 3: Ratio between test and retest values of UIC in not exposed 
patients (n = 25).
5.90±2.18 μmol/L (paired t-test, p = 0.43). In this small 
group (n = 25) the ratio between the test and the retest 
value of the UIC had a median of 1.05 (range 0.47–3.29). 
The intra-class correlation coefficient was 0.73 for UIC, 
0.82 for creatinine and 0.64 for the UIC:creatinine ratio 
(Figure 3).
A positive relationship was found between UIC 
and creatinine in not exposed patients (n = 469, r = 0.42, 
F = 99.8, p < 0.001) (Figure 4). The equation of the linear 
regression was: Y = 2.35X+4.28. UIC was normalized on a 
subject-by-subject basis to urinary creatinine concentra-
tion. However, normalization of UIC to creatinine concen-
tration increased the inter-subject variability of UIC (% 
CV = 96% vs. 66%) (Table 1).
Thyroid volume was significantly smaller in women 
than in men (n = 34, 24.6±14.4  mL vs. 38.1±16.8  mL) 
(p = 0.031). UIC was significantly lower in women 
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necessary to rule out iodine contamination in the nuclear 
medicine setting. The advantageous profiles of potentio-
metric methods have been previously highlighted and a 
rapid development of the technique has been advocated 
[20, 24, 26–28]. Nowadays, several potentiometric devices 
have been developed and are commercially available. In 
Switzerland, validation of commercially available poten-
tiometric devices is ensured by the manufacturer before 
the release on the market. Moreover, only verification tests 
and routine quality controls are needed for their clinical 
use (www.seco.admin.ch/sas).
Knowledge of UIC is very important for the manage-
ment of patients affected by benign or malignant thyroid 
diseases. Guidelines regarding the management of the dif-
ferentiated thyroid cancer recommend a low iodine diet for 
about 2 weeks prior to radioiodablation, postponement of 
radioiodine ablation when the UIC is above 150–300 μg/L, 
or for at least 3 months after intravenous infusion of iodi-
nated contrast agents or after withdrawal of amiodar-
one [9–11]. However, recent studies showed that 1 month 
could be sufficient to allow recovery after exposure to 
hydrophilic iodinated contrast agents for neck or chest 
(6.44±3.84  μmol/L) than in men (8.42±4.10 μmol/L) 
(p = 0.026). After correcting for thyroid volume, the gender 
difference in UIC lost statistical significance (F = 0.60, 
p = 0.44).
UIC was also plotted against other variables of inter-
est. No significant relationship was found between UIC 
and age (n = 123, F = 0.11, p = 0.74), between UIC and body 
weight (n = 101, F = 1.16, p = 0.28) or between UIC and urine 
pH (n = 14, F = 0.081, p = 0.78). Neither plasma concentration 
of total or free triiodothyronine nor plasma concentration 
of thyroxine correlated with UIC either in the whole group 
or in each of the different subgroups (data not shown).
One typical example illustrating the importance of 
knowledge of UIC for the differential diagnosis of hyper-
thyroidism is shown in Figure 5.
Discussion
In this study we have used a commercially available poten-
tiometric method to investigate the distribution of UIC in 
patients with thyroid disease not exposed to non-radioac-
tive iodine and to assess group differences in UIC among 
different groups of patients with thyroid diseases exposed 
and not exposed to non-radioactive iodine. Results indi-
cated that the technique allows stratification of UIC 
according to the clinical diagnosis, as desirable. This 
method has the noteworthy advantage of being inexpen-
sive and more rapid in comparison to many others [12–14]. 
Therefore, other than being manual, the potentiometric 
method is gifted with all favorable characteristics that are 
Figure 4: Linear regression between UIC and creatinine urinary 
concentration in not exposed patients (n = 469).
The regression equation was: Y = 2.35X+4.28 (r = 0.42, F = 3.4, 
p < 0.001).
Figure 5: Example illustrating the importance of knowledge of UIC 
for the differential diagnosis of hyperthyroidism.
Patient #1 is a 75-year-old man who developed subclinical hyper-
thyroidism after 7 years of medical therapy with amiodarone. The 
patient was asymptomatic. Laboratory results showed: TSH  ≤  0.01 
mU/L (0.3–4.2), free triiodothyronine (fT3) = 7.7 pmol/L (3.1–6.8) and 
free thyroxine (fT4) was 27.2 pmol/L (12.0–22.0), antibodies against 
thyroperoxidase (TPO-Ab): 14 U/mL (0–34), antibodies against TSH 
(TRAb):  < 0.3 IU/L ( < 1.8). Neck echography showed a thyroid with 
normal volume and slightly reduced perfusion. 99mTc-pertechnetate 
scintigraphy showed no significant tracer uptake in the thyroid 
region and visualization of salivary glands. Thyroid uptake was 
0.2% (0.5%–2.0%). UIC was 56.2 μmol/L. A subacute thyroiditis de 
Quervain with hyperthyroid onset was excluded and the ultimate 
diagnosis was type 2 amiodarone-induced thyrotoxicosis.
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computed tomography [29, 30]. Conversely, after exposure 
to lipophilic hepatobiliary agents or to amiodarone, UIC 
may remain increased for several months [31, 32].
Our results replicated previous findings indicat-
ing a large variability in UIC [2–5, 33–35]. To reduce the 
 variability of the single spot UIC, normalization to urine 
creatinine (expressed in μg iodine/g creatinine) has 
been often adopted. Unfortunately, creatinine values are 
dependent on sex, age and muscular mass [33, 34], which 
mandates the collection of a huge database before reliable 
clinical application and requires a more cumbersome defi-
nition of normal values according to these variables [4, 7]. 
The effect of creatinine on the variability of the measure-
ment of UIC is also disputed. For example, Kim et al. found 
that the 24-h urinary iodine excretion correlated more 
strongly with the iodine:creatinine ratio rather than with 
the simple UIC [36]. Other authors discourage the use of 
the iodine:creatinine ratio because of its higher variability 
[2, 35]. Our results are consistent with the latter observa-
tion and fail to give evidence of a substantial advantage 
in normalization to urine creatinine levels. Measurements 
of creatinine are more reliable than measurements of UIC 
in the single subject, but the lack of a strong relationship 
between the physiology of iodine and the physiology of 
creatinine makes the ratio UIC:creatinine in this sample 
less useful.
In the literature several units have been used to refer 
to UIC, even though most international societies, including 
the WHO, adopted μg/L. Our potentiometric methodology 
expresses UIC directly in μmol/L according to the guide-
lines of the International System of Units, but results can 
easily be transformed in μg/L after multiplication for the 
molecular weight of iodine (126.9 Dalton). Observation of 
Table 1 reveals that median UIC in not exposed patients 
(688 μg/L) is about 2–3 times higher than the upper range 
of the normal values obtained with the Sandell-Kolthoff 
reaction (300 μg/L) [3, 37] and that the higher limit of the 
95% confidence interval (2376 μg/L) is about eight times 
higher. This apparent bias is most likely due to the fact 
that acid environment of urine favors the formation of the 
anionic form I– against the neutral molecular form I2. This 
explains why the vast majority (up to  > 90%) of total iodine 
in the urine is present as iodide (I–) [12]. Since ISE-based 
potentiometry measures exclusively I–, while the Sandell-
Kolthoff reaction measures only I2, systematically higher 
UIC in this study was expected. Another possible explana-
tion is that the acid reactant used in the Sandell-Kolthoff 
reaction might reduce the catalytic activity of I2 [15, 16] and 
thereby possibly underestimate the real concentration of I2 
in the urine. According to the first hypothesis, to compare 
the potentiometric I–-based UIC expressed in μg/L to the 
results of the I2-based Sandell-Kolthoff reaction, a division 
of the UIC potentiometric value (expressed in μg/L after 
multiplication for the molecular weight of iodine) for the 
presumed I–/I2 ratio in the urine of 9 [12] is necessary. Alter-
natively, the corrected potentiometric I–-based UIC in μg/L 
can be obtained by multiplying the original UIC expressed 
in μmol/L for the single correction factor of 14.1.
The distribution of UIC in this sample showed that 
the 2.5% CI and the 97.5% CI equaled 1.48 μmol/L and 
18.72 μmol/L, respectively. Based on the descriptive analy-
sis and visual inspection of the histogram, an upper value of 
20 μmol/L could be adopted to exclude iodine contamina-
tion when applying radioactivity. This is a reasonable prac-
tical rounding of the 97.5% confidence interval that could 
be used to minimize false positives. Even though calcula-
tion based on literature values [12] need to be interpreted 
with caution especially when dealing with a relatively small 
sample, it is interesting to note that 20 μmol/L, calculated 
with the I–-based potentiometric method, corresponds after 
transformation to 280 μg/L of the I2-based Sandell-Kolthoff 
reaction and compares favorably with the limit of 300 μg/L 
set by the WHO to define normal UIC [3]. Recommenda-
tion of a cut-off between 150 and 300 μg/L [9–11] suggests 
that UIC cut-off might be adapted to the clinical setting. 
However, because of the very limited number of patients 
studied with scintigraphy and uptake measurements, we 
currently do not have any element to support clinically 
adapted thresholds and suggest that the same threshold of 
20 μmol/L be used for both diagnostic imaging and therapy.
Our study also indicates that while the vast majority 
of normal subjects can be easily differentiated by patients 
recently exposed to iodine, there is a gray zone around 
20–30 μmol/L, where some overlap takes place and the 
differential diagnosis may be difficult if the anamnesis is 
not conclusive. Indeed a factor 2–3 variability in the UIC 
is encountered occasionally also in subjects not exposed 
to iodine, despite the overall reliability of the technique 
is good (intra-class correlation coefficient = 0.73; median 
test-retest ratio = 1.05). The sources of variability in UIC 
are multiple and include circadian rhythms, sensitivity 
to hydration, and exposure to dietary or environmental 
iodine [38, 39]. As a consequence, in selected patients 
who have borderline UIC and are candidates to therapy, 
it might be preferable to repeat UIC after one or few days 
before proceeding to the application of radioactivity.
The main limit of the study, which is due to the ret-
rospective design, is that we could not systemically 
assess the UIC threshold at which a sizable  inhibition 
of thyroid uptake occurs. Thyroid uptake of 131I and 
 99mTc-pertechnetate were inversely proportional to UIC 
[40, 41]. The dynamics of the iodine overload on thyroid 
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function and scintigraphic patterns are indeed complex, 
and depend on several factors including time from expo-
sure, amount of iodine, pattern (acute vs. chronic) of 
exposure and chemical form of the iodinated compound 
[31, 32, 40, 42, 43].
A second limit of the study, which is also inherent 
to the retrospective design, is that our results could not 
be directly compared to those obtained with the Sandell-
Kolthoff reaction.
In summary, we have applied a commercially avail-
able iodine-selective ISE-based potentiometric method for 
measurement of UIC in patients with thyroid disease. This 
preliminary clinical application suggests that using the 
ISE-based potentiometric technique allows reliable meas-
urement of UIC and clinical decision-making. This method 
is inexpensive, rapid and it can be successfully applied as 
an alternative to existing methods for excluding iodine 
contamination before administration of diagnostic or 
therapeutic amounts of radiopharmaceuticals. The tech-
nique provides values of UIC that compare favorably with 
those obtained by well established, yet more expensive 
and cumbersome, techniques.
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